Peripheral arterial disease: Medical management in primary care practice

Geriatrics

Volumn 56, Issue 4, 2001, Pages 20-30

  Weiner, S D ^a   Reis, E D ^a   Kerstein, M D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; GENE PRODUCT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTACYCLIN; STATIN; TICLOPIDINE; VASCULOTROPIN; VASODILATOR AGENT;

ANGIOPLASTY; ARTERY DISEASE; ATHEROSCLEROSIS; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; DRUG EFFECT; GENE THERAPY; HUMAN; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOPHYSIOLOGY; PRIMARY MEDICAL CARE; REVASCULARIZATION; REVIEW; RISK FACTOR;

AGED; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; DIABETIC ANGIOPATHIES; FAMILY PRACTICE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 0035068476     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study
2. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
3. The pathogenesis of atherosclerosis: A perspective for the 1990s
4. Prevalence of hypertension in the U.S. adult population: Results from the third National Health and Nutrition Examination Survey, 1988-1991
5. High blood pressure and end-organ damage
6. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus
7. Peripheral neuropathies in diabetes
8. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
9. Molecular genetic insights into cardiovascular disease
10. Cigarette smoking as a risk factor for stroke. The Framingham study
11. Tobacco: Its impact on vascular disease
12. Delivery rates for preventive services in 44 midwestern clinics
13. Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice
14. The noninvasive vascular laboratory
15. Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease
16. Magnetic resonance angiography of lower extremity arterial disease
17. Exercise training improves functional status in patients with peripheral arterial disease
18. Benefits and recommendations for physical activity programs for all Americans
19. Control of lipid disorders in patients with atherosclerotic vascular disease
20. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
21. Pharmacologic management of peripheral vascular disease
22. Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study
23. Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study
24. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease
25. Antithrombotic therapy in peripheral arterial occlusive disease
26. Clinical applications of thrombolytic therapy for arterial and graft occlusion
27. Coagulation alterations due to local fibrinolytic therapy with recombinant tissue type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease
28. Balloon angioplasty, stenting, and role of atherectomy